Skip to main content
. 2018 Apr 1;11(4):2032–2037.

Figure 2.

Figure 2

Knockdown LOXL1 inhibits GLIOMA cell proliferation and growth. (A) Expression of LOXL1 is significantly down-regulated in indicated cell lines after stably silencing LOXL1. Silencing LOXL1 inhibits U87MG (A) and U251 (B) cell viability. (B, C) Knockdown LOXL1 inhibits the cell viability of U87MG (B) and U251 (C). (D, E) Knockdown LOXL1 inhibits the ability of clone formation in U87MG and U251. (F, G) Depletion of LOXL1 leads to U87MG and U251 cell cycle arrest in G0/G1 stage. (G) Silencing LOXL1 inhibits subcutaneous tumor formation in nude mice.